Tissue Papers segment generates record quarterly results
KINGSEY FALLS, QC, Nov. 9, 2023 - Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period ended September 30, 2023.
Q3 2023 Highlights
- Sales of $1,198 million (compared with $1,168 million in Q2 2023 and $1,174 million in Q3 2022);
- Operating income of $80 million (compared with $64 million in Q2 2023 and $25 million in Q3 2022);
- Net earnings per common share of $0.34 (compared with net earnings per common share of $0.22 in Q2 2023 and a net loss per common share of ($0.02) in Q3 2022);
- Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA (A)1) of $161 million (compared with $141 million in Q2 2023 and $111 million in Q3 2022);
- Adjusted net earnings per common share1 of $0.44 (compared with $0.27 in Q2 2023 and $0.20 in Q3 2022);
- Net debt1 of $2,088 million as of September 30, 2023 (compared with $2,076 million as of June 30, 2023). Net debt to EBITDA (A) ratio1 of 3.8x, down from 4.1x as of June 30, 2023;
- Total capital expenditures, net of disposals, of $56 million in Q3 2023, compared to $104 million in Q2 2023. The Corporation's 2023 forecasted net capital expenditures of approximately $325 million is unchanged.
- Sales of $1,198 million (compared with $1,168 million in Q2 2023 and $1,174 million in Q3 2022);
- Operating income of $80 million (compared with $64 million in Q2 2023 and $25 million in Q3 2022);
- Net earnings per common share of $0.34 (compared with net earnings per common share of $0.22 in Q2 2023 and a net loss per common share of ($0.02) in Q3 2022);
- Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA (A)1) of $161 million (compared with $141 million in Q2 2023 and $111 million in Q3 2022);
- Adjusted net earnings per common share1 of $0.44 (compared with $0.27 in Q2 2023 and $0.20 in Q3 2022);
- Net debt1 of $2,088 million as of September 30, 2023 (compared with $2,076 million as of June 30, 2023). Net debt to EBITDA (A) ratio1 of 3.8x, down from 4.1x as of June 30, 2023;
- Total capital expenditures, net of disposals, of $56 million in Q3 2023, compared to $104 million in Q2 2023. The Corporation's 2023 forecasted net capital expenditures of approximately $325 million is unchanged.
Mario Plourde, President and CEO, commented: "We are pleased with our solid third quarter results. Sequential sales growth of 2.6% reflects stronger Containerboard volume and more favourable sales mix in Tissue Papers. Quarterly EBITDA (A)1 improved 14%, exceeding expectations, fuelled by a robust 39% increase in Tissue Papers as benefits from lower raw material costs, price increases, and repositioning of this segment's operational platform and other profitability, efficiency and productivity initiatives undertaken over the past year continued to yield results. Sequentially, raw material costs were a headwind for our packaging businesses, but remained below prior year levels, while production costs were a tailwind. Notwithstanding a less favourable exchange rate, we maintained our net debt levels stable due to strong cash flows from operations and lower capital expenditures during the quarter. Consequently, our leverage ratio1 improved to 3.8x from 4.1x at the end of Q2."
Discussing near-term outlook, Mr. Plourde commented, "On a consolidated basis, we are forecasting fourth quarter results to decrease sequentially. This is driven by lower expected results in our Containerboard segment due to higher raw material costs, slightly lower average selling prices and usual softer seasonal volumes in the fourth quarter. Results in the Specialty Packaging and Tissue Papers segments are expected to remain stable on a sequential basis. More broadly, we continue to remain prudent on the demand-side, most notably in our packaging businesses, due to general economic uncertainty. Notwithstanding this, we are very pleased with the continued ramp-up of production at the Bear Island facility, and the benefits being realized in our Tissue Papers segment following the wide-ranging measures executed in recent quarters. In both cases, the benefits from these strategic actions will continue to generate long-term commercial and competitive advantages for Cascades and sustainable value for our shareholders."
Source: Cascades
Legal Notice: Paper Advance is not responsible for the accuracy or availability of content on external websites.
